Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

David Scadden

Director at Agios Pharmaceuticals, Inc. (AGIO)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $25K

Reported trades

Filed Stock Type Shares Price Value Since
Nov 14SEC AGIOAgios Pharmaceuticals, Inc. Sell Plan 20017,603 held (−1%) $43.84 $9K -28.6%
Oct 10SEC AGIOAgios Pharmaceuticals, Inc. Sell Plan 20017,603 held (−1%) $41.00 $8K -23.6%
Oct 2SEC AGIOAgios Pharmaceuticals, Inc. Sell Plan 20017,603 held (−1%) $40.00 $8K -21.7%
  • Sell

    Director David Scadden sold $9K of AGIO at $43.84 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director David Scadden sold $8K of AGIO at $41.00 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director David Scadden sold $8K of AGIO at $40.00 — pre-scheduled 10b5-1 plan sale.